Sarah Js Glickman is Director of bluebird bio, Inc.. Currently has a direct ownership of 0 shares of BLUE, which is worth approximately $0. The most recent transaction as insider was on Nov 11, 2021, when has been sold 0 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Sarah JS Glickman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2021
BUY
Other acquisition or disposition
-
0 Added 0.0%
0 Common Stock
Sep 29 2021
BUY
Grant, award, or other acquisition
-
4,663 Added 50.0%
4,663 Common Stock

Also insider at

CRTO
Criteo S.A. Communication Services
TSVT
2seventy bio, Inc. Healthcare
ATR
APTARGROUP, INC. Healthcare
SJG

Sarah Js Glickman

Director
New York, NY

Track Institutional and Insider Activities on BLUE

Follow bluebird bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE